Although the global germline mutation prevalence in medulloblastoma is about 1% [13], a study showed that in nearly half (9/20) of patients with TP53-mutated medulloblastoma, the mutation was found to be germline [10]. The gene discussed is TP53; the disease is medulloblastoma.